MacroGenics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; MacroGenics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is €-0.60. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 10.72M	$ 10.40M	$ 6.02M	$ 24.50M	$ 73.10M
Gross Profit	$ 10.56M	$ 10.31M	$ 13.80M	$ 20.97M	$ 71.31M
EBIT	$ -45.42M	$ -25.90M	$ -40.85M	$ -38.01M	$ 11.10M
EBITDA	$ -45.24M	$ -25.82M	$ -39.07M	$ -35.40M	$ 14.00M
Net Income Common Stockholders	$ -46.07M	$ 24.10M	$ 57.47M	$ -38.01M	$ 12.80M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 100.96M	$ 89.90M	$ 108.76M	$ 224.26M	$ 108.88M
Total Assets	$ 298.42M	$ 339.97M	$ 305.65M	$ 343.50M	$ 280.47M
Total Debt	$ 33.97M	$ 34.11M	$ 34.32M	$ 34.55M	$ 34.83M
Net Debt	$ -66.98M	$ -55.79M	$ -74.44M	$ -189.72M	$ -74.05M
Total Liabilities	$ 145.81M	$ 145.99M	$ 134.11M	$ 234.23M	$ 138.46M
Stockholders Equity	$ 152.61M	$ 193.98M	$ 171.54M	$ 109.27M	$ 142.01M
Cash Flow	-
Free Cash Flow	$ -28.66M	$ -35.73M	$ -2.32M	$ -13.19M	$ 28.93M
Operating Cash Flow	$ -28.04M	$ -35.25M	$ -2.09M	$ -12.83M	$ 29.32M
Investing Cash Flow	$ 38.82M	$ -33.52M	$ -113.48M	$ 28.09M	$ -5.79M
Financing Cash Flow	$ 273.00K	$ 49.91M	$ 59.00K	$ 100.12M	$ 1.36M

Currency in USD

MacroGenics Earnings and Revenue History

Income Statement >

MacroGenics Debt to Assets

Balance Sheet >

MacroGenics Cash Flow

Cash Flow >

MacroGenics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing